日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

MicroRNA prognostic markers for immune checkpoint inhibitor success in urologic cancers

泌尿系统癌症免疫检查点抑制剂疗效的microRNA预后标志物

期刊:Immunotherapy
影响因子:2.3
doi:10.1080/1750743X.2026.2640756
Vlachostergios, Panagiotis J; Evmorfopoulos, Konstatinos; Marsitopoulos, Konstantinos; Tamposis, Ioannis; Samara, Maria; Thodou, Eleni; Sarantis, Panagiotis; Matthaios, Dimitrios; Karamouzis, Michalis V; Tzortzis, Vassilios; Giakountis, Antonis
肿瘤
肿瘤免疫
免疫/内分泌
发表日期：2026
文献求助 收藏

Detection rates for prostate cancer using PI-RADS 2.1 upgrading rules in transition zone lesions align with risk assessment categories: a systematic review and meta-analysis

使用PI-RADS 2.1升级规则检测移行区病变的前列腺癌检出率与风险评估类别一致：系统评价和荟萃分析

期刊:European Radiology
影响因子:4.7
doi:10.1007/s00330-025-11618-w
Agrotis, Georgios; Pooch, Eduardo Pais; Marsitopoulos, Kostas; Vlychou, Marianna; Benndorf, Matthias; Beets-Tan, Regina G H; Schoots, Ivo G
肿瘤
前列腺癌
肿瘤免疫
发表日期：2025
文献求助 收藏

Serum Levels of Urokinase Plasminogen Activator Receptor (suPAR) Discriminate Moderate Uncontrolled from Severe Asthma

血清尿激酶型纤溶酶原激活物受体 (suPAR) 水平可区分中度未控制哮喘和重度哮喘

期刊:Journal of Personalized Medicine
影响因子:3
doi:10.3390/jpm12111776
Kotsiou, Ourania S; Pantazopoulos, Ioannis; Mavrovounis, Georgios; Marsitopoulos, Konstantinos; Tourlakopoulos, Konstantinos; Kirgou, Paraskevi; Daniil, Zoe; Gourgoulianis, Konstantinos I
uPAR
信号转导
uPA
哮喘
发表日期：2022
文献求助 收藏